SPONSORED CONTENT The purpose of the 340B drug pricing program remains a contested question between 340B providers and some in [...] …
More From Our Sponsor:
Maxor
Maxor
340B INDUSTRY LEADER SPOTLIGHT
Abel Haile, Senior Director, Health System Strategy & Commercial Analytics, Maxor National Pharmacy Services
SPONSORED CONTENT The 340B Drug Pricing Program is at a crossroads, facing increased scrutiny, manufacturer restrictions, and ongoing legal battles. [...] …
SPONSORED CONTENT The healthcare system is undergoing a major transformation, with a growing emphasis on value-based care and outcomes-based payment [...] …
SPONSORED CONTENT The 340B program continues to be a central topic of discussion in the pharmaceutical landscape, especially as specialty [...] …
SPONSORED CONTENT As a pharmacist and executive pharmacy leader, I nodded in affirmation when reading McKinsey & Company describe pharmacy [...] …
340B INDUSTRY LEADER SPOTLIGHT
Jason Atlas, Senior Vice President, Pharmacy Operations, Maxor National Pharmacy Services
SPONSORED CONTENT Every dollar counts when you’re serving an underserved population. However, many organizations fail to incorporate a holistic approach [...] …
